CSIMarket
 


Vir Biotechnology Inc   (VIR)
Other Ticker:  
 

Vir Biotechnology Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


Return On Equity (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change 145.34 % 164.74 % 207.4 % 99.74 % -
Y / Y Net Income Change 58.76 % - - - -
Net Income (TTM) in Millions 1,143 1,078 1,216 529 -102
Return On Equity (TTM) 60.66 % 68.86 % 96.39 % 57.2 % -
Total Ranking # 151 # 155 # 100 # 238 # 0
Equity (TTM) in Millions 2,150 1,952 2,001 1,432 876
Seq. Equity Change 10.14 % -2.45 % 39.75 % 63.4 % 18.85 %
Seq. Net Income Change -329.19 % - - - -


Roe Comment
Vir Biotechnology Inc returned in III. Quarter 60.66 % on shareholder's equity, that was lower than company average return on equity.

ROE detoriated compare to previous period, despite net income growth.

Within Healthcare sector 30 other companies have achieved higher return on equity. While Return on equity total ranking has deteriorated compare to previous quarter from 155 to 166.

What is ROE?
Return On Equity Company Ranking
Within: No.
Industry # 8
Sector # 31
Overall # 166

Return On Equity Statistics
High Average Low
96.39 %
70.78 %
57.2 %
(Mar 31 2022)   (Dec 31 2021)


Annual Return On Equity (Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019


Total Equity in Millions 1,432 717 424 0 0
Y / Y Equity Change 99.74 % 69.09 % - - -
Net Income in Millions 529 -299 -175 0 0
Y / Y Net Income Change - - - - -
Return On Equity 36.92 % -41.66 % -41.2 % - -





Annual Roe Comment
In 2021 ROE improved to 36.92 % compare to previous year, due to net income growth.


Financial Statements
Vir Biotechnology Inc 's Equity $ 2,150 Millions VIR's Balance sheet
Vir Biotechnology Inc 's Income $ 175 Millions Quarterly VIR's Income Statement
VIR's Income by Division See VIR's Income by Division

More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
Roe Trends for overall market
VIR's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for VIR's Competitors
Return On Equity for Vir Biotechnology Inc 's Suppliers
Roe for VIR's Customers

You may also want to know
VIR's Roa VIR's Inventory Turnover Ratio VIR's Growth Rates VIR's Dividend Statistics
VIR's Profitability Ratios VIR's Asset Turnover Ratio VIR's Dividend Growth
VIR's Roi VIR's Valuation Ratios VIR's Financial Strength Ratios VIR's Dividend Payout Ratio



Companies with similar Return On Equity at Sep 30 2022, within Healthcare Sector ROE
Chimerix inc   147.04 %
Harpoon Therapeutics Inc   128.27 %
Biofrontera Inc   105.90 %
Davita Inc   105.42 %
Halozyme Therapeutics Inc   95.77 %
Vicarious Surgical Inc   91.41 %
Biomx Inc   89.58 %
Dynavax Technologies Corporation  89.49 %
Abbvie Inc   85.92 %
Puma Biotechnology Inc   83.55 %
Maravai Lifesciences Holdings Inc   75.23 %
Aptevo Therapeutics Inc   74.95 %
Moderna Inc   70.03 %
Oncotelic Therapeutics Inc   69.60 %
Sensus Healthcare Inc   66.57 %
Selecta Biosciences Inc  66.02 %
Siga Technologies Inc  65.91 %
Eli Lilly And Company  64.45 %
Journey Medical Corporation  64.37 %
Kiniksa Pharmaceuticals Ltd   64.16 %
Harmony Biosciences Holdings inc   62.81 %
Science 37 Holdings Inc   60.98 %
Vir Biotechnology Inc   60.66 %
Innoviva Inc   58.51 %
Glucotrack Inc   57.65 %
Tenet Healthcare Corp  52.50 %
Sesen Bio Inc   51.11 %
Orgenesis Inc   49.74 %
Cryo cell International Inc   49.59 %
Prophase Labs Inc   48.24 %



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ACVA's Profile

Stock Price

ACVA's Financials

Business Description

Fundamentals

Charts & Quotes

ACVA's News

Suppliers

ACVA's Competitors

Customers & Markets

Economic Indicators

ACVA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071